Back
Amgen 10K Form
Buy
62
AMGN
Amgen
Last Price:
269.04
Seasonality Move:
9.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-31 | 10Q | AMGN/Amgen Quarterly |
| 2023-08-04 | 10Q | AMGN/Amgen Quarterly |
| 2023-04-28 | 10Q | AMGN/Amgen Quarterly |
| 2023-02-09 | 10K | AMGN/Amgen Annual |
| 2022-11-04 | 10Q | AMGN/Amgen Quarterly |
| 2022-08-05 | 10Q | AMGN/Amgen Quarterly |
Receive AMGN News And Ratings
See the #1 stock for the next 7 days that we like better than AMGN
AMGN Financial Statistics
Sales & Book Value
| Annual Sales: | $26.32B |
|---|---|
| Cash Flow: | $2.51B |
| Price / Cash Flow: | 15.43 |
| Annual Sales: | $14.31 |
| Price / Book: | 18.81 |
Profitability
| EPS (TTM): | 14.07000 |
|---|---|
| Net Income (TTM): | $7.57B |
| Gross Margin: | $19.92B |
| Return on Equity: | 139.6% |
| Return on Assets: | 9.5% |
Amgen Earnings Forecast
Key Amgen Financial Ratios
- The Gross Profit Margin over the past 39 years for AMGN is 75.66%.
- The Selling, General & Administrative Expenses for AMGN have been equal to 20.57% of Gross Profit Margin.
- The Research & Development expenses have been 16.84% of Revenue.
- The Interest Expense is 21.46% of Operating Income.
- The Net Earning history of AMGN is 24.89% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 25 years.
Amgen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | AMGN |
| CUSIP: | 031162 |
| Website: | amgen.com |
Debt
| Debt-to-Equity Ratio: | 7.9 |
|---|---|
| Current Ratio: | 2.86 |
| Quick Ratio: | 2.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.22 |
|---|---|
| Forward P/E Ratio: | 13.52 |